The Philippines Food and Drug Administration is inviting stakeholder feedback on a proposed abridged process for evaluating applications to conduct certain clinical trials by relying on approvals granted for these studies by a “stringent” regulatory authority.
The reliance process would apply to clinical trials targeting public health emergencies, rare diseases, cancer, HIV/AIDS or emerging or re-emerging infectious
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?